NCT04055571
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
Recruiting
Not specifiedAges 18+ObservationalMethodist Health SystemInvestigator-initiated
~500 participants
Updated 2026-06-10 on ClinicalTrials.gov
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Overall survival
Measured over 2005 to 2019
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Dhiresh Jeyarajah, M.D. · PRINCIPAL_INVESTIGATOR · Methodist Richardson Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
• All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present
Age ≥18 years
Exclusion
• Patients that are not diagnosed with or treated for pancreatic diseases
Age \< 18 years
What this trial measures
- Overall survival2005 to 2019
Number of patients who have been diagnosed with benign or malignant pancreatic disease